| Condition | Key Finding | Association | Board Exam Tip |
| Pheochromocytoma | Episodic headache, paroxysmal hypertension | Catecholamine excess; _1 receptors | Always block _1 first (e.g., Phenoxybenzamine) before -blockers to prevent hypertensive crisis. |
| Benign Prostatic Hyperplasia (BPH) | Urinary retention/dribbling | _1 receptor overactivity at the bladder neck | Use _1-antagonists ({Prazosin}, {Tamsulosin}) for symptomatic relief; use 5-reductase inhibitors (Finasteride) for long-term prostate shrinkage. |
| Cocaine Intoxication | Vasoconstriction, nasal ischemia/septum | Blocks NE reuptake at the synapse | Never give a -blocker in suspected cocaine overdose because it blocks necessary _2 vasodilation, causing severe hypertension. |
| Hydralazine-induced Dima | Peripheral edema (Dima) | Dilates pre-capillary arterioles ( hydrostatic pressure) | Counteract with post-capillary venodilators like {ACE} inhibitors; safe in pregnancy (H-M-L-M). |
| Topic | Key Point | Context | Exam Relevance |
| Somatic vs Autonomic | Somatic = 1 neuron; Autonomic = 2 neurons. | Motor cortex -> Ventral horn (Alpha motor) for somatic control. | Remember the two-neuron chain and the specific neurotransmitter release at each synapse. |
| Sympathetic Pathway | Short pre, Long post. NE released from post-ganglionic fibers. | Ganglia are close to vertebral bodies. | The primary sympathetic action is vasoconstriction (_1). |
| Parasympathetic Pathway | Long pre, Short post. A Ch released from post-ganglionic fibers. | Ganglia are located within the target organ walls (e.g., Meissner's/Plexus). | The primary parasympathetic action is rest and digest (Muscarinic effects). |
| _1 Blockade | {Prazosin} or {Tamsulosin}. | BPH treatment; blocks receptors at the bladder neck. | Differentiate between immediate symptomatic relief (-blocker) vs. long-term shrinkage (5-reductase inhibitor). |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient with a history of chronic steroid use presents with profound hypotension during surgery and requires high doses of IV glucocorticoids. | Secondary Adrenal Insufficiency (Steroid Crisis) | Chronic exogenous steroids suppress the HPA axis, requiring stress-dose steroids to maintain cortisol levels during acute stress. |
| A 70-year-old male complains of difficulty initiating urination and urinary dribbling. The physician administers a {Prazosin} or {Tamsulosin}. | Benign Prostatic Hyperplasia (BPH) Management | These drugs are _1-antagonists, blocking the constrictive effect of _1 receptors at the bladder neck to promote urinary outflow. |
| A patient with a pheochromocytoma is undergoing surgical resection and develops severe hypertension. The pre-operative regimen involves administering an _1-blocker followed by a -blocker. | Pheochromocytoma Crisis Management Protocol | Blocking _1 first prevents massive vasoconstriction, which would otherwise precipitate a hypertensive crisis upon removal of the tumor mass. |
| A patient is given a combination of {Hydralazine} and an {ACE} inhibitor for hypertension. | Preventing Dima with Vasodilators | Hydralazine causes vasodilation by dilating pre-capillary arterioles, increasing capillary hydrostatic pressure; {ACE} inhibitors counteract this by acting as post-capillary venodilators. |
| A patient is intoxicated with cocaine and presents with severe hypertension and tachycardia. The initial treatment administered in the emergency department is a benzodiazepine. | Cocaine Overdose Management | Benzodiazepines are first-line agents for agitation/seizures; -blockers must be avoided because they block necessary _2 vasodilation, worsening hypertension. |
| A patient with suspected spinal muscular atrophy presents at 6 months of age and exhibits tongue fasciculations. | Spinal Muscular Atrophy (SMA) | SMA is an autosomal recessive disorder caused by SMN1 gene mutation leading to death of alpha motor neurons in the ventral horn. |
| Key Features | Distinguishing Findings | Next Step |
| _1 Blockers (Prazosin, Tamsulosin) | Symptomatic relief; blocks receptors at the bladder neck. | Used for acute/symptomatic management of urinary retention. |
| 5-Reductase Inhibitors (Finasteride, Dutasteride) | Long-term prostate shrinkage; lowers DHT levels. | Used as primary therapy to reduce prostatic volume and prevent recurrence. |
| Key Features | Distinguishing Findings | Next Step |
| _1 Blockers (e.g., Prazosin) | Cause vasodilation, leading to orthostatic hypotension. | Must be combined with caution when giving other peripheral vasodilators (e.g., {PDE}-5{i}, Nitrates). |
| Hydralazine | Dilates pre-capillary arterioles; increases capillary hydrostatic pressure. | Monitor for Dima; use post-capillary venodilator ({ACE} inhibitor) to counteract the effect. |
| Condition | Association | Mechanism | Clinical Significance |
| Pheochromocytoma | Catecholamine excess | Excessive release of NE/Epi acting on _1 receptors. | Requires sequential blockade (_1 -> ) before surgery to prevent hypertensive crisis. |
| BPH | {Prazosin} / {Tamsulosin} use | _1-receptor antagonism at the bladder neck. | Provides rapid symptomatic relief of urinary retention, but does not shrink the prostate long-term. |
| Cocaine Intoxication | Vasoconstriction/Nasal ischemia | Blocks NE reuptake; high local concentration of NE causes severe vasoconstriction. | -blockers are contraindicated because they prevent necessary _2 mediated vasodilation, worsening hypertension. |
| Hydralazine-induced Dima | Peripheral edema (Dima) | Dilates pre-capillary arterioles ( hydrostatic pressure). | Use post-capillary venodilators ({ACE} inhibitors) to counteract the effect; safe in pregnancy. |
| Term | Definition | Context | Example |
| _1-Agonist | Activates _1 receptors, causing smooth muscle contraction. | Used for decongestion or reversing hypotension post-anesthesia. | Pseudoephedrine, Ephedrine. |
| PNMT | Phenylethanolamine N-methyltransferase; enzyme that converts NE to Epi. | Found uniquely in the adrenal medulla. | This conversion allows the adrenal gland to release epinephrine into circulation. |
| _1-Antagonist | Blocks _1 receptors, causing smooth muscle relaxation/dilation. | Used for BPH or pheochromocytoma management. | Prazosin, Tamsulosin (selective), Phenoxybenzamine (non-selective). |
| 5-Reductase Inhibitor | Enzyme inhibitor that prevents testosterone conversion to DHT. | Long-term treatment for BPH and prostate enlargement. | Finasteride, Dutasteride. |
| Topic | Study Approach | Priority | Resources |
| Autonomic Physiology | Master the 2-neuron chain (pre/post) and neurotransmitter release at each synapse. | High | Review diagrams of sympathetic vs parasympathetic ganglia location. |
| Receptor Pharmacology | Use mnemonics ({CUTESIES HAVE ONE M\&M}, {MAC2s}) to link receptors to G protein pathways. | Very High | Practice linking receptor type (e.g., _1) to its primary physiological effect (vasoconstriction). |
| Drug Interactions | Create a flow chart for drug combinations, especially vasodilators and catecholamine excess. | High | Focus on the mechanism of interaction (e.g., {ACE} inhibitors acting as venodilators). |
⚠️The "All or Nothing" Light's Criteria Trap: Assuming all three criteria (protein ratio > 0.5, LDH ratio > 0.6, etc.) must be positive to classify an effusion as exudative; only one is needed. (Note: This trap was not in the transcript but is a general high-yield mistake).